30 research outputs found
Oxytocin receptor gene polymorphisms are associated with human directed social behavior in dogs (Canis familiaris)
The oxytocin system has a crucial role in human sociality;
several results prove that polymorphisms of the oxytocin
receptor gene are related to complex social behaviors in humans.
Dogs' parallel evolution with humans and their adaptation to the
human environment has made them a useful species to model human
social interactions. Previous research indicates that dogs are
eligible models for behavioral genetic research, as well. Based
on these previous findings, our research investigated
associations between human directed social behaviors and two
newly described (−212AG, 19131AG) and one known (rs8679684)
single nucleotide polymorphisms (SNPs) in the regulatory regions
(5′ and 3′ UTR) of the oxytocin receptor gene in German Shepherd
(N = 104) and Border Collie (N = 103) dogs. Dogs' behavior
traits have been estimated in a newly developed test series
consisting of five episodes: Greeting by a stranger, Separation
from the owner, Problem solving, Threatening approach, Hiding of
the owner. Buccal samples were collected and DNA was isolated
using standard protocols. SNPs in the 3′ and 5′ UTR regions were
analyzed by polymerase chain reaction based techniques followed
by subsequent electrophoresis analysis. The gene–behavior
association analysis suggests that oxytocin receptor gene
polymorphisms have an impact in both breeds on (i) proximity
seeking towards an unfamiliar person, as well as their owner,
and on (ii) how friendly dogs behave towards strangers, although
the mediating molecular regulatory mechanisms are yet unknown.
Based on these results, we conclude that similarly to humans,
the social behavior of dogs towards humans is influenced by the
oxytocin system
DNA methylation of the glucagon-like peptide 1 receptor (GLP1R) in human pancreatic islets
Background: Insulin secretion is enhanced upon the binding of Glucagon-like peptide-1 (GLP-1) to its receptor (GLP1R) in pancreatic β cells. Although a reduced expression of GLP1R in pancreatic islets from type 2 diabetic patients and hyperglycaemic rats has been established, it is still unknown if this is caused by differential DNA methylation of GLP1R in pancreatic islets of type 2 diabetic patients.Methods: In this study, DNA methylation levels of 12 CpG sites close to the transcription start site of GLP1R were analysed in pancreatic islets from 55 non-diabetic and 10 type 2 diabetic human donors as well as in β and α cells isolated from human pancreatic islets. DNA methylation of GLP1R was related to GLP1R expression, HbA levels and BMI. Moreover, mRNA expression of MECP2, DNMT1, DNMT3A and DNMT3B was analysed in pancreatic islets of the non-diabetic and type 2 diabetic donors.Results: One CpG unit, at position +199 and +205 bp from the transcription start site, showed a small increase in DNA methylation in islets from donors with type 2 diabetes compared to non-diabetic donors (0.53%, p=0.02). Furthermore, DNA methylation levels of one CpG site located 376 bp upstream of the transcription start site of GLP1R correlated negatively with GLP1R expression (rho=-0.34, p=0.008) but positively with BMI and HbA (rho=0.30, p=0.02 and rho=0.30, p=0.03, respectively). This specific CpG site is located in an area with known SP1 and SP3 transcription factor binding sites. Moreover, when we compared the DNA methylation of the GLP1R promoter in isolated human β and α cells, we found that it was higher in α- compared with β-cells (p=0.009). Finally, there was a trend towards decreased DNMT3A expression (p=0.056) in type 2 diabetic compared with non-diabetic islets.Conclusions: Together, our study shows that while BMI and HbA are positively associated with DNA methylation levels of GLP1R, its expression is negatively associated with DNA methylation of GLP1R in human pancreatic islets